Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden
· Delayed Price · Currency is SEK 0.2376
-0.0128 (-5.11%)
May 23, 2025, 5:29 PM CET
Xbrane Biopharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -160.65 | -266.22 | -388.17 | -172.51 | -188.38 | -226.03 | Upgrade
|
| Depreciation & Amortization | 24.1 | 24.21 | 21.43 | 16.58 | 12.22 | 5.77 | Upgrade
|
| Other Amortization | - | - | - | - | - | 0.79 | Upgrade
|
| Stock-Based Compensation | - | - | - | - | - | 1.29 | Upgrade
|
| Other Operating Activities | 60.54 | 67.22 | 145.36 | -7.25 | -5.04 | -1.61 | Upgrade
|
| Change in Accounts Receivable | -6.81 | -4.56 | -85.13 | 1.7 | -61.09 | -51.33 | Upgrade
|
| Change in Inventory | -47.79 | -166 | -56.6 | -50.26 | - | - | Upgrade
|
| Change in Accounts Payable | 42.65 | 212.82 | 22.57 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | 17.83 | 22.67 | 32.7 | Upgrade
|
| Operating Cash Flow | -89.16 | -133.73 | -406.68 | -193.92 | -219.61 | -238.41 | Upgrade
|
| Capital Expenditures | - | -0.5 | -6.79 | -11.62 | -27.68 | -3.86 | Upgrade
|
| Sale (Purchase) of Intangibles | -75.76 | -51.75 | -9.98 | -48.51 | -49.67 | - | Upgrade
|
| Investing Cash Flow | -75.76 | -52.25 | -16.77 | -60.13 | -77.35 | -3.86 | Upgrade
|
| Long-Term Debt Issued | - | 70 | 225 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -126.14 | -34.74 | -8.34 | -7.27 | -3.14 | Upgrade
|
| Total Debt Repaid | -99.17 | -126.14 | -34.74 | -8.34 | -7.27 | -3.14 | Upgrade
|
| Net Debt Issued (Repaid) | -59.17 | -56.14 | 190.26 | -8.34 | -7.27 | -3.14 | Upgrade
|
| Issuance of Common Stock | - | 337.24 | 120.02 | 170.55 | 380.87 | 346.45 | Upgrade
|
| Other Financing Activities | -19.97 | -37.48 | -11.58 | -13.35 | -24.23 | -20.58 | Upgrade
|
| Financing Cash Flow | -79.14 | 243.62 | 298.7 | 148.86 | 349.37 | 322.72 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.56 | 0.84 | -4.49 | 4.05 | 1.39 | -1.52 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0.58 | 0.44 | 0.64 | -0.05 | -1.76 | - | Upgrade
|
| Net Cash Flow | -245.05 | 58.93 | -128.59 | -101.19 | 52.04 | 78.94 | Upgrade
|
| Free Cash Flow | -89.16 | -134.23 | -413.47 | -205.53 | -247.29 | -242.26 | Upgrade
|
| Free Cash Flow Margin | -32.09% | -67.55% | -173.20% | -356.72% | -2309.16% | - | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.11 | -14.40 | -8.04 | -10.48 | -13.38 | Upgrade
|
| Cash Interest Paid | 17.65 | 17.65 | 7.58 | 2.59 | 2.64 | 0.69 | Upgrade
|
| Levered Free Cash Flow | -108.3 | -67 | -244 | -169.78 | -279.72 | -153.39 | Upgrade
|
| Unlevered Free Cash Flow | -88.98 | -45.98 | -232.43 | -168.17 | -278.07 | -152.96 | Upgrade
|
| Change in Net Working Capital | -23.92 | -106.21 | 53.48 | 38.06 | 109.45 | 22.31 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.